Myeloproliferative disease
|
group |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
365
|
43
|
0.200 |
None |
0.988 |
173 |
|
1996 |
2020 |
Chronic myeloproliferative disorder
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
366
|
47
|
0.100 |
None |
0.975 |
159 |
|
1993 |
2020 |
Neoplasm, Residual
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
329
|
23
|
0.100 |
None |
1.000 |
76 |
|
1992 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
0.930 |
71 |
|
1988 |
2019 |
Leukemia, Myelocytic, Acute
|
disease |
Neoplasms
|
Neoplastic Process
|
3111
|
6892
|
0.100 |
None |
0.928 |
69 |
|
1989 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
0.957 |
47 |
|
1988 |
2019 |
Primary Myelofibrosis
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
282
|
29
|
0.100 |
None |
1.000 |
41 |
|
1995 |
2019 |
Congenital chromosomal disease
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Congenital Abnormality
|
757
|
47
|
0.100 |
None |
0.972 |
36 |
|
1990 |
2017 |
Acute leukemia
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
639
|
50
|
0.100 |
None |
0.968 |
31 |
|
1989 |
2017 |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
644
|
23
|
0.600 |
None |
0.960 |
25 |
|
1998 |
2019 |
Hematologic Neoplasms
|
group |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
827
|
60
|
0.100 |
None |
1.000 |
24 |
|
1993 |
2019 |
Myelofibrosis
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
163
|
7
|
0.100 |
None |
1.000 |
19 |
|
1995 |
2019 |
Lymphoid leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
288
|
4
|
0.100 |
None |
1.000 |
15 |
|
1993 |
2019 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.400 |
None |
1.000 |
13 |
|
1999 |
2018 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.400 |
None |
1.000 |
13 |
|
1999 |
2018 |
MYELODYSPLASTIC SYNDROME
|
group |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1033
|
95
|
0.100 |
None |
1.000 |
12 |
|
1996 |
2012 |
Ph-Like Acute Lymphoblastic Leukemia
|
disease |
|
Neoplastic Process
|
30
|
1
|
0.100 |
None |
0.750 |
12 |
|
2012 |
2019 |
Malignant transformation
|
phenotype |
|
Neoplastic Process
|
1027
|
20
|
0.100 |
None |
1.000 |
11 |
|
1988 |
2020 |
CML progression
|
disease |
|
Neoplastic Process
|
47
|
3
|
0.100 |
None |
1.000 |
11 |
|
2010 |
2018 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.400 |
None |
0.900 |
10 |
|
1993 |
2019 |
Hematopoietic Neoplasms
|
group |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
322
|
2
|
0.100 |
None |
1.000 |
10 |
|
2003 |
2018 |
Nephroblastoma
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
586
|
125
|
0.100 |
None |
1.000 |
10 |
|
2004 |
2018 |
Monosomy
|
group |
Pathological Conditions, Signs and Symptoms
|
Congenital Abnormality
|
214
|
11
|
0.090 |
None |
0.778 |
9 |
|
1987 |
2019 |
Pre B-cell acute lymphoblastic leukemia
|
disease |
|
Neoplastic Process
|
90
|
5
|
0.090 |
None |
1.000 |
9 |
|
1993 |
2019 |
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
145
|
21
|
0.090 |
None |
1.000 |
9 |
|
1996 |
2018 |